VAERS reports by lot

Merck HPV lot M041212: VAERS reports

29 VAERS reports list lot M041212 as a Merck HPV vaccine, received between 2017-03-24 and 2020-03-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
14%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1522%
Neurological1116%
General / Systemic (non-local)710%
Musculoskeletal69%
Dermatological (non-injection-site)69%
Respiratory57%
Gastrointestinal57%
Allergic / Anaphylactic46%
Cardiac / Cardiovascular34%
Autoimmune / Immune-mediated34%
Psychiatric / Neuropsychiatric23%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina3
Pennsylvania3
Texas3
Virginia2
West Virginia2
Florida2
Illinois2
Missouri2
Michigan1
Massachusetts1
Montana1
New Jersey1

Reports by month received

2017-032
2017-042
2017-056
2017-064
2017-074
2017-082
2017-091
2017-101
2017-111
2018-082
2018-101
2019-041
2019-051
2020-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.